Effects of epinephrine and amrinone on contractility and cyclic adenosine monophosphate generation of tumor necrosis factor α-exposed cardiac myocytes

Critical Care Medicine

Volumn 27, Issue 2, 1999, Pages 286-292

  Kumar, Anand ^a   Kosuri, Raju ^a   Kandula, Prasad ^a   Dimou, Cathy ^a   Allen, Jill ^a   Parrillo, Joseph E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenergic agents; Amrinone; Cyclic AMP; Cytokine; Epinephrine; Heart contractility; Inotropes; Interleukin 1 ; Myocardium; Phosphodiesterase inhibitors; Septicemia; Tumor necrosis factor

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR STIMULATING AGENT; AMRINONE; CYCLIC AMP; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRITICAL ILLNESS; CYCLIC AMP BLOOD LEVEL; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; INOTROPISM; MUSCLE EXCITATION; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 0032957149     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199902000-00032     Document Type: Article

References (37)

1. 1. Parker MM, McCarthy KE, Ognibene FP, et al: Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
2. 2. Parker MM, Shelhamer JH, Bacharach SL, et al: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483-490
3. 3. Ognibene FP, Parker MM, Natanson C, et al: Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. Chest 1988; 93:903-910
4. 4. Jones SB, Romano RD: Myocardial beta adrenergic receptor coupling to adenylate cyclase during developing septic shock. Circ Shock 1990; 30:51-61
5. 5. Silverman HJ, Penaranda R, Orens JB, et al: Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hypo-responsiveness to catecholamines. Crit Care Med 1993; 21:31-39
6. 6. Parrillo JE, Burch C, Shelhamer JH, et al: A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest 1985; 76:1539-1553
7. 7. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor-alpha and interleukin-1 beta are responsible for depression of in vitro myocardial cell contractility induced by serum from humans with septic shock. J Exp Med 1996; 183:949-958
8. 8. Karzai W, Reilly JM, Hoffman WD, et al: Hemodynamic effects of dopamine, norepinephrine and fluids in a dog model of sepsis. Abstr. Am J Physiol 1995; 268:H692-H702
9. 9. Parratt JR: Myocardial and circulatory effects of E. coli endotoxin. Modification of responses to catecholamines. Br J Pharmacol 1973; 47:12-25
10. 10. Werner HA, Herbertson MJ, Walley KR: Amrinone increases ventricular contractility and diastolic compliance in endotoxemia. Am J Respir Crit Care Med 1995; 152:496-502
11. 11. Harary I, Farley B: In vitro studies of single isolated beating rat heart cells. Science 1960; 131:1674-1675
12. 12. Cooper RH, McPherson M, Schofield JG: The effect of prostaglandins on ox pituitary content of adenosine 3':5'-cyclic monophosphate and the release of growth hormone. Biochem J 1972; 127:143-154
13. 13. Hedeker D, Gibbons RD, Waternaux C, et al: Investigating drug plasma levels and clinical response using random regression models. Psychopharmacology Bulletins 1989; 25:227-231
14. 14. Colucci WS, Wright RF, Braunwald E: New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. I. N Engl J Med 1986; 314:290-299
15. 15. Colucci WS, Wright RF, Braunwald E: New positive inotropic agents in the treatment of heart failure. Mechanisms of action and recent clinical developments. II. N Engl J Med 1986;314: 349-358
16. 16. Kass D, Grayson R, Marino P: Pressure-volume analysis as a method for quantifying simultaneous drug (amrinone) effects on arterial load and contractile state in vivo. JACC 1990; 16:726-732
17. 17. Konstram MA, Cohen SR, Weiland DS, et al: Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Am J Cardiol 1986; 57:242-248
18. 18. Bressack MA, Raffin TA: Importance of venous return, venous resistance, and mean circulatory pressure in the physiology and management of shock. Chest 1987; 92:906-912
19. 19. Romano RD, Jones SB: Characteristics of myocardial beta-adrenergic receptors during endotoxicosis in the rat. Am J Physiol 1986; 251:R359-R364
20. 20. Shepherd RE, Lang CH, McDonough KH: Myocardial adrenergic responsiveness after lethal and nonlethal doses of endotoxin. Am J Physiol 1987; 252: H410-H416
21. 21. Bohm M, Kirchmayr R, Gierschik P, et al: Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am J Med 1995; 98:183-186
22. 22. Reithmann C, Hallstrom S, Pilz G, et al: Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock. Circ Shock 1993; 41: 48-59
23. 23. Balligand JL, Ungureanu D, Kelly RA, et al: Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 1993; 91:2314-2319
24. 24. Chung MK, Gulick TS, Rotondo RE, et al: Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myoctyes: Impairment of signal transduction. Circ Res 1990; 67:753-763
25. 25. Kumar A, Brar R, Sun E, et al: Tumor necrosis factor (TNF) impairs isoproterenol-stimulated cardiac myocyte contractility and cyclic AMP production via a nitric oxide-independent mechanism. Abstr. Crit Care Med 1996; 24:A95
26. 26. Gulick T, Chung MK, Pieper SJ, et al: Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte adrenergic responsiveness. Proc Natl Acad Sci 1989; 86:6753-6757
27. 27. Hermiller JB, Mehegan JP, Nadkarni VM, et al: Amrinone during porcine intraperitoneal sepsis. Circ Shock 1991; 34:247-251
28. 28. Barton P, Garcia J, Kouatli A, et al: Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Abstr. Chest 1996; 109:1302-1312
29. 29. Kumar A, Schupp E, Bunnell E, et al: The cardiovascular response to dobutamine in septic shock. Abstr. Clin Invest Med 1994; 17:B18,107
30. 30. Taylor SH, Verma SP, Hussain M, et al: Intravenous amrinone in left ventricular failure complicated by acute myocardial infarction. Am J Cardiol 1985; 56(Suppl):29B
31. 31. Sung BH, Robinson C, Thadani U, et al: Effects of 1-epinephrine on hemodynamics and cardiac function in coronary disease: Dose response studies. Clin Pharmacol Ther 1988; 43:308-316
32. 32. Ensinger H, Weichel T, Lindner KH, et al: Effects of norepinephrine, epinephrine, and dopamine on oxygen consumption in volunteers. Crit Care Med 1993; 21:1502-1508
33. 33. Finkel MS, Oddis CV, Jacobs TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389
34. 34. Kumar A, Kosuri R, Thota V, et al: Nitric oxide and cyclic GMP generation mediates human septic serum-induced in vitro cardiomyocyte depression. Abstr. Chest 1993; 104:12S
35. 35. Shahid M, Rodger IW: Enhancement of amrinone-induced positive inotropy in rabbit papillary muscles with depressed contractile function: Effects on cyclic nucleotide levels and phosphodiesterase isoenzymes. J Pharm Pharmacol 1991; 43:88-94
36. 36. de Boelpaepe C, Vincent JL, Contempre B, et al: Combination of norepinephrine and amrinone in the treatment of endotoxin shock. J Crit Care 1989; 4:202-207
37. 37. Jones JL, Gengo PJ, Dodam JR, et al: Amrinone combined with dobutamine improves hemodynamics and oxygen delivery without down-regulation of cardiac beta-adrenergic receptor density in porcine endotoxemia. Shock 1995; 3:224-234